Back to Results
First PageMeta Content
Motor neurone disease / Cell biology / Rare diseases / Stem cell treatments / Amyotrophic lateral sclerosis / ALS Therapy Development Institute / Spinal muscular atrophy / Stem cell / Cell therapy / Biology / Stem cells / Biotechnology


Media Contacts: Chris Airriess, CSC-COO, [removed], [removed]Robert Goldstein, ALS TDI, [removed], [removed]EMBARGOED FOR RELASE UNTIL[removed]at 8:00AM (EST) California Stem Cell and
Add to Reading List

Document Date: 2010-06-14 10:53:48

Open Document

File Size: 78,46 KB

Share Result on Facebook

City

IRVINE / CAMBRIDGE / /

Company

California Stem Cell Inc. / ALS TDI / /

Country

United States / /

/

Facility

About ALS Therapy Development Institute / California facility / ALS Therapy Development Institute / /

IndustryTerm

therapeutic product / manufacturing / non-profit biotechnology / treatment of this fatal neurodegenerative disease / treatment of fatal neurodegenerative disease / /

MedicalCondition

Lou Gehrig's disease / transverse myelitis / Lou Gehrig’s disease / Spinal Muscular Atrophy / disease / neurodegenerative disease / ALS / progressive paralysis / amyotrophic lateral sclerosis / another degenerative disease / ALS disease / terrible disease / potential ameliorating disease / multiple sclerosis / fatal neurodegenerative disease / disorders / spinal cord injury / /

MedicalTreatment

stem cell therapy / /

Organization

ALS Therapy Development Institute / FDA / /

Person

Steve Perrin / Chris Airriess / Lou Gehrig / /

/

Position

chief executive officer and chief scientific officer / chief / /

ProvinceOrState

California / Massachusetts / /

Technology

MotorGraftTM technology / cell therapy / biotechnology / gene expression / stem cells / drug screening / at advancing a potential stem cell therapy / /

URL

www.als.net / /

SocialTag